High TSH With a Normal T4: What to Do, by TSH Level and Age
A TSH above range with a free T4 inside range is called subclinical hypothyroidism. The pituitary is pushing harder to keep the thyroid output normal. Whether that needs treatment depends on how high TSH is, your age and whether you have symptoms, and the major guidelines do not fully agree. The step they share is to repeat TSH and free T4, with thyroid peroxidase (TPO) antibodies, after 2 to 3 months before deciding anything. This page is for people who are not already on thyroid medicine.
Covers 4 situations
ETA, BMJ and TRUST evidence
Free, no account needed
Key takeaways
- Subclinical hypothyroidism means TSH is raised and free T4 is in range. The 2013 ETA guideline splits it into 4.0 to 10.0 mU/L (mild) and above 10 mU/L, and asks for a repeat TSH, free T4 and TPO antibodies after 2 to 3 months before any decision.
- Treatment is where guidelines split. ETA recommends levothyroxine under age 65 to 70 with TSH above 10, even without symptoms. The 2019 BMJ guideline makes a strong recommendation against thyroid hormones in adults with subclinical hypothyroidism, after 21 trials of 2,192 people showed no clinically relevant benefit.
- TRUST, a trial of 737 adults aged 65 or older with TSH 4.60 to 19.99 mIU/L, found no apparent benefit from levothyroxine. The exceptions in the BMJ guideline are women trying to conceive, TSH above 20, severe symptoms and adults 30 or younger.
Four situations behind a high TSH with a normal T4
They differ in what to do next, not in the lab pattern. TSH band, age and TPO antibodies are what separate them.
Which situation is closest to yours?
Answer from your report and your age. This is a map of what guidelines say, not advice to start or avoid treatment.
What is your TSH (in mIU/L, the same unit as mU/L)?
How old are you?
How old are you?
Closest match on this page
Mildly raised TSH (4.0 to 10 mU/L) Most commonAutoimmune thyroiditis that is progressing Watch the trend
Want the rest of your thyroid and lipid markers read with it?
Upload your report and FixFirst reads TSH, free T4, cholesterol and iron markers together, since a raised TSH often moves LDL and ferritin too.
Upload My Report
Closest match on this page
Mildly raised TSH (4.0 to 10 mU/L) Most commonOlder adults (65 and over, especially 80+) Usually watch
Want the rest of your thyroid and lipid markers read with it?
Upload your report and FixFirst reads TSH, free T4, cholesterol and iron markers together, since a raised TSH often moves LDL and ferritin too.
Upload My Report
Closest match on this page
TSH above 10 mU/L Guidelines lean toward treatmentAutoimmune thyroiditis that is progressing Watch the trend
Want the rest of your thyroid and lipid markers read with it?
Upload your report and FixFirst reads TSH, free T4, cholesterol and iron markers together, since a raised TSH often moves LDL and ferritin too.
Upload My Report
Closest match on this page
TSH above 10 mU/L Guidelines lean toward treatmentOlder adults (65 and over, especially 80+) Usually watch
Want the rest of your thyroid and lipid markers read with it?
Upload your report and FixFirst reads TSH, free T4, cholesterol and iron markers together, since a raised TSH often moves LDL and ferritin too.
Upload My Report
Closest match on this page
TSH above 10 mU/L Guidelines lean toward treatment
The BMJ guideline excludes TSH above 20 mIU/L from its recommendation against treatment. At this level the question is not whether to talk to a clinician but how soon.
Want the rest of your thyroid and lipid markers read with it?
Upload your report and FixFirst reads TSH, free T4, cholesterol and iron markers together, since a raised TSH often moves LDL and ferritin too.
Upload My Report
Mildly raised TSH (4.0 to 10 mU/L) Most common Check: Repeat TSH, Free T4, TPO antibodies after 2-3 months
The ETA calls TSH of 4.0 to 10.0 mU/L mildly increased. This is the band the BMJ guideline and TRUST speak to most directly: 21 trials found no clinically relevant benefit from thyroid hormones for quality of life, symptoms, depressive symptoms, fatigue or body mass index, so the advice is to monitor progression or resolution. ETA allows a trial of levothyroxine in younger patients with symptoms suggestive of hypothyroidism, reviewed 3 to 4 months after TSH reaches the reference range, and stopped if there is no improvement. TRUST's placebo group saw TSH fall from 6.40 to 5.48 mIU/L over a year with no treatment.
TSH above 10 mU/L Guidelines lean toward treatment Check: Repeat TSH + Free T4, TPO antibodies, lipid panel, heart history
ETA recommends levothyroxine for patients under 65 to 70 with TSH above 10 mU/L even when there are no symptoms. The Korean Thyroid Association guideline says treatment is necessary in this band if coronary artery disease or heart failure is present, and notes that meta-analyses link severe subclinical hypothyroidism (TSH above 10) to higher risks of heart failure and coronary artery disease, though not in people 65 or older. The BMJ guideline excludes TSH above 20, where the evidence base is different. The tell: a repeat TSH that stays above 10 and a low-normal free T4.
Autoimmune thyroiditis that is progressing Watch the trend Check: TPO antibodies, serial TSH and Free T4, thyroid ultrasound if advised
The Korean guideline lists the risk factors for progression to overt hypothyroidism: a higher TSH and a lower free T4 at diagnosis, positive TPO antibodies, TSH doubling at follow-up, female sex and thyroiditis. This is why the repeat test includes TPO antibodies and not TSH alone. A rising TSH with a free T4 drifting toward the bottom of its range is the trend that moves a clinician toward treatment even in the mild band.
Older adults (65 and over, especially 80+) Usually watch Check: Age-specific reference range, repeat TSH, falls and heart history
TRUST enrolled 737 adults aged 65 or older with TSH 4.60 to 19.99 mIU/L and found no apparent benefit from levothyroxine. ETA says the oldest old (over 80 to 85) with TSH of 10 or under should be followed with a wait-and-see strategy, generally without hormone treatment, and recommends age-specific local reference ranges. The Korean guideline does not indicate treatment for mild subclinical hypothyroidism in people 70 or older (a strong recommendation). The tell: age, with a TSH in the mild band.
What to do next, in order
The first step is the same for everyone. The rest depends on the TSH band and age above.
Where the guidelines land, by TSH band and age (the Korean guideline uses its own region-specific TSH reference range, so its bands start higher)
| TSH and age | ETA 2013 | BMJ 2019 / TRUST | Korean TA 2023 |
|---|---|---|---|
| 4.0 to 10, under 65 to 70 | Repeat; trial only if symptomatic | Against hormones (BMJ) | Generally not recommended |
| 4.0 to 10, 70 and over | Wait and see (over 80 to 85) | No benefit in 65+ (TRUST) | Not indicated |
| Above 10, under 65 to 70 | Levothyroxine recommended | Against hormones (BMJ), except above 20 | Necessary with CAD or heart failure |
| Above 10, 70 and over | Not specified for this group | No benefit in 65+ (TRUST, TSH up to 19.99) | Generally not recommended |
1
Repeat TSH and free T4, and add TPO antibodies, after 2 to 3 months
This is the step the ETA and the Korean guideline share. A single raised TSH is not enough to act on. The repeat gives the trend, and TPO antibodies show whether autoimmune thyroiditis is the cause, which predicts progression. A TSH that has settled back into range changes the picture. A TSH that has risen changes it the other way.
2
Mild band, older adult: monitoring is the usual answer
TRUST, the BMJ guideline and the ETA all point toward watchful waiting here. The Korean guideline does not indicate treatment for mild subclinical hypothyroidism in people 70 or older (a strong recommendation). Monitoring means repeat TSH and free T4 at intervals a clinician sets, not no follow-up.
3
TSH above 10: this is a conversation about treatment, not a self-help step
ETA recommends levothyroxine under 65 to 70 at this level. The Korean guideline considers it necessary with coronary artery disease or heart failure. The BMJ guideline leaves TSH above 20 outside its scope. If levothyroxine is started, ETA re-checks TSH 2 months later and aims for a stable TSH in the lower half of the reference range, 0.4 to 2.5 mU/L, monitored at least yearly after that.
4
Symptoms with a mild TSH: ask what a trial would look like
ETA allows a trial of levothyroxine in younger patients with symptoms suggestive of hypothyroidism and TSH under 10. It asks for a review 3 to 4 months after TSH reaches the reference range, and for the treatment to be stopped if symptoms have not improved. The BMJ guideline reached the opposite conclusion from 21 trials, which is why this is a decision to make with a clinician, not a default.
This page covers 2 markers. Your actual report probably has 30+.
A raised TSH tends to travel with other markers: LDL cholesterol and ferritin are the two this site sees most. If a real report is behind these numbers, upload it and FixFirst reads them together.
Check my full report
The numbers behind the decision
Three sources, three kinds of evidence: a guideline, a pooled review of trials and a single large trial.
4.0–10 mU/L
ETA's mild band; above 10 is the severe band
The 2013 ETA guideline splits subclinical hypothyroidism into mildly increased TSH (4.0 to 10.0 mU/L) and more severe (above 10 mU/L), and asks for a repeat TSH, free T4 and TPO antibodies after 2 to 3 months.
Source: ETA guideline, Eur Thyroid J 2013
21 trials
2,192 adults, no clinically relevant benefit from thyroid hormones
The BMJ Rapid Recommendations panel found no benefit for quality of life, thyroid-related symptoms, depressive symptoms, fatigue or BMI, and made a strong recommendation against thyroid hormones. It does not apply to women trying to conceive, TSH above 20, severe symptoms or adults 30 or younger.
Source: Bekkering et al., BMJ 2019
737 adults
aged 65 or older, TSH 4.60 to 19.99, levothyroxine vs placebo
TRUST found no apparent benefit from levothyroxine in older persons with subclinical hypothyroidism. TSH fell from a 6.40 mean to 5.48 in the placebo group over a year.
Source: Stott et al., NEJM 2017
When this page does not apply
The evidence above has stated exclusions. These situations need a clinician's advice from the start.
Women trying to become pregnant or already pregnantThe BMJ recommendation excludes women trying to conceive, and the Korean guideline advises active treatment for women planning pregnancy. A raised TSH in pregnancy has its own thresholds.
TSH above 20 mIU/LOutside the BMJ guideline's recommendation. This level needs prompt clinical review.
Marked symptomsThe BMJ panel notes its recommendation may not apply to patients with severe symptoms.
Adults aged 30 or youngerThe BMJ recommendation may not apply to young adults, and ETA is most willing to treat in the younger group.
Anyone already taking levothyroxineA high TSH on treatment is a dose question, not subclinical hypothyroidism. ETA's treatment target is a stable TSH in the lower half of the reference range.
Frequently asked questions
What happens if TSH is higher than normal?
With a normal free T4, it means the pituitary is pushing harder to keep thyroid hormone output in range, which is called subclinical hypothyroidism. Most people have a mild rise and no clear symptoms. Some progress to overt hypothyroidism, and the Korean guideline lists the risk factors: a higher TSH and lower free T4 at diagnosis, positive TPO antibodies, TSH doubling at follow-up, female sex and thyroiditis. The usual first step is a repeat TSH, free T4 and TPO antibodies after 2 to 3 months.
Do I need to treat a high TSH with a normal T4?
It depends, and guidelines disagree. ETA recommends levothyroxine under 65 to 70 with TSH above 10 mU/L, and a trial in symptomatic younger patients with TSH under 10. The BMJ guideline made a strong recommendation against thyroid hormones in adults after 21 trials of 2,192 people showed no clinically relevant benefit, with exceptions for women trying to conceive, TSH above 20, severe symptoms and adults 30 or younger. TRUST found no apparent benefit in adults 65 or older.
What are the optimal ranges for thyroid hormone levels?
Laboratories print their own reference range, commonly with an upper limit near 4 to 4.5 mIU/L. The US NHANES study of 17,353 disease-free people reported an upper limit of 4.5, and a figure of 4.12 mIU/L is cited for iodine-sufficient regions. On levothyroxine, the ETA aims for a stable TSH in the lower half of the reference range, 0.4 to 2.5 mU/L. TSH blood test covers the ranges in detail.
Will high TSH cause weight gain?
Overt hypothyroidism is associated with weight gain, but a mildly raised TSH with a normal T4 is a smaller effect. In the 21 trials the BMJ panel reviewed, thyroid hormones had no clinically relevant effect on body mass index in adults with subclinical hypothyroidism. A raised TSH is rarely the reason for weight gain on its own.
Does a high TSH with normal T4 go away on its own?
Sometimes. In TRUST, TSH in the placebo group fell from a 6.40 mean to 5.48 mIU/L over a year with no treatment. That is why ETA asks for a repeat TSH, free T4 and TPO antibodies after 2 to 3 months before any decision. Part of that drift can be regression to the mean, which is what a repeat test is for.
Is a high TSH with normal T4 the same as hypothyroidism?
Not yet. Overt hypothyroidism means TSH is raised and free T4 is low. Subclinical hypothyroidism means TSH is raised and free T4 is in range. High TSH covers the overt pattern and the symptoms.
Can a high TSH raise cholesterol or lower ferritin?
Thyroid hormone affects LDL clearance and iron absorption, which is why a raised TSH often travels with high LDL or low ferritin on the same panel. High TSH with high LDL and high TSH with low ferritin cover each pairing.
References & Guidelines
- Pearce SH, et al. — 2013 ETA Guideline: Management of Subclinical Hypothyroidism, Eur Thyroid J, PubMed
- Bekkering GE, et al. — Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline, BMJ 2019, PubMed
- Stott DJ, et al. — Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism (TRUST), N Engl J Med 2017, PubMed
- Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guidelines, Endocrinol Metab, PMC
Medical disclaimer: This page is for general educational purposes only. Thyroid results need to be read with your symptoms, history, medicines and a repeat test. The information here does not constitute medical advice and should not replace clinical assessment.
Free · No account · 45 seconds
See which of your flags a raised TSH could explain
Upload your blood report and FixFirst reads TSH, free T4, cholesterol and iron markers together, so you see which flags may share one thyroid cause.
Read my thyroid markers →Any lab PDF or phone photo · Processed in memory, never stored
FixFirst is free, with no ads and no account. If this guide helped, a coffee keeps it that way.